Skip to main content
Event Details
Registration Information
Hotel and Travel Info
Welcome & Accessibility Policy
ASCPT Code of Conduct
Full Schedule
View Full Program
AI Pre-Con
Clinical Trial Pre-Con
Browse by Date
Tuesday, March 26, 2024
Wednesday, March 27, 2024
Thursday, March 28, 2024
Friday, March 29, 2024
Browse by Community
Posters
Browse by Title
Browse by Presenter
Browse by Poster Session
Browse by Community
ePoster Gallery
Login Required
Speakers
Presidential Trainees
Partners & Opportunities
Awardees
Career Center
ASCPT Volunteer Survey
Toggle navigation
Login
Search
Home
+
Event Details
Registration Information
Hotel and Travel Info
Welcome & Accessibility Policy
ASCPT Code of Conduct
+
Full Schedule
View Full Program
AI Pre-Con
Clinical Trial Pre-Con
+
Browse by Date
Tuesday, March 26, 2024
Wednesday, March 27, 2024
Thursday, March 28, 2024
Friday, March 29, 2024
Browse by Community
+
Posters
Browse by Title
Browse by Presenter
Browse by Poster Session
Browse by Community
ePoster Gallery
Login Required
Speakers
Presidential Trainees
Partners & Opportunities
Awardees
Career Center
ASCPT Volunteer Survey
Home
Browse by Poster Presenter
Browse by Poster Presenter
17 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Abdelgawad, Ibrahim
AbbVie
PII-051
-
ELRANATAMAB INTEGRATED EXPOSURE-RESPONSE (ER) EFFICACY AND SAFETY ANALYSES IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) USING A CLINICAL UTILITY INDEX (CUI)
Ibrahim Abdelgawad
Favorite
Abdelhady, Ahmed
Intellia Therapeutics
PII-121
-
IMPLEMENTATION OF QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING IN TRANSLATION AND DOSE SELECTION FOR FIRST-IN-HUMAN PHASE 1/2 CLINICAL STUDY OF NTLA-2002 IN THE TREATMENT OF HEREDITARY ANGIOEDEMA
Ahmed Abdelhady
Favorite
Aboshady, Omar
College of Pharmacy, Purdue University
OAI-001
-
CHANGES IN QTC ACROSS DIFFERENT TRIMESTERS OF PREGNANCY AND PRE-ECLAMPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Omar Aboshady
Favorite
PII-007
-
CHANGES IN QTC ACROSS DIFFERENT TRIMESTERS OF PREGNANCY AND PRE-ECLAMPSIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Omar Aboshady
Favorite
Adeluola, Adeoluwa
The Ohio State University
PII-048
-
APPARENT FCRN DYSFUNCTION IN CANCER CACHEXIA DECREASES EXTRAVASCULAR IMMUNOGLOBULIN G ABSORPTION.
Adeoluwa Adeluola
Favorite
Adeojo, Lilian
Arcus Biosciences Inc.
LB-022
-
MULTIPLE ELIMINATION PATHWAYS ARE RESPONSIBLE FOR THE ELIMINATION OF ETRUMADENANT (ETRUMA) AFTER ORAL ADMINISTRATION OF [14C]-ETRUMA TO HUMANS.
Lilian Adeojo
Favorite
Akinola, Lois
U.S. Food and Drug Administration
PT-024
-
EVIDENCE SUPPORTING EFFICACY EXTRAPOLATIONS FOR TARGETED THERAPIES ACROSS MOLECULARLY DEFINED SUBSETS OF DISEASES IN THE ABSENCE OF SUBSET-SPECIFIC CLINICAL DATA.
Lois Akinola
Favorite
PWI-004
-
EVIDENCE SUPPORTING EFFICACY EXTRAPOLATIONS FOR TARGETED THERAPIES ACROSS MOLECULARLY DEFINED SUBSETS OF DISEASES IN THE ABSENCE OF SUBSET-SPECIFIC CLINICAL DATA.
Lois Akinola
Favorite
AL Nebaihi, Hamdah
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta
PII-183
-
POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF PF-07265803 AND ITS METABOLITE IN PATIENTS WITH LAMIN A/C RELATED DILATED CARDIOMYOPATHY.
Hamdah AL Nebaihi
Favorite
Alaei, Samaneh
Abbvie Inc
PII-119
-
IMPACT OF CRUSHING OR GRINDING ON THE RELATIVE BIOAVAILABILITY OF THE VENETOCLAX TABLETS.
Samaneh Alaei
Favorite
Almond, Lisa
Certara UK (Simcyp)
CT-006
-
APPLICATION OF PBPK TO ASSESS THE IMPACT OF UGT1A1 GENOTYPE ON DOLUTEGRAVIR EXPOSURE IN PREGNANT WOMEN AND FETUSES
Lisa Almond
Favorite
CT-007
-
APPLICATION OF PBPK TO SUPPLEMENT CLINICAL DATA AND INVESTIGATE THE IMPACT OF UGT1A1 PHENOTYPE ON DOLUTEGRAVIR EXPOSURE IN AFRICAN BREASTFED INFANTS
Lisa Almond
Favorite
PII-161
-
APPLICATION OF PBPK TO ASSESS THE IMPACT OF UGT1A1 GENOTYPE ON DOLUTEGRAVIR EXPOSURE IN PREGNANT WOMEN AND FETUSES
Lisa Almond
Favorite
PII-162
-
APPLICATION OF PBPK TO SUPPLEMENT CLINICAL DATA AND INVESTIGATE THE IMPACT OF UGT1A1 PHENOTYPE ON DOLUTEGRAVIR EXPOSURE IN AFRICAN BREASTFED INFANTS
Lisa Almond
Favorite
Alshameri, Naifah
University of Florida
PT-021
-
DNA METHYLATION PATTERNS OF ARA-C, DAUNORUBICIN, AND ETOPOSIDE PHARMACOKINETIC/PHARMACODYNAMIC GENES ARE ASSOCIATED WITH THE CLINICAL OUTCOMES IN AML.
Naifah Alshameri
Favorite
Alshammari, Raed
College of Pharmacy, University of Florida
PT-006
-
A GENOME-WIDE DNA METHYLATION ANALYSIS REVEALS DIFFERENT METHYLATION PATTERNS AND MECHANISTIC CLUES OF MEDICATION-RELATED OSTEONECROSIS OF THE JAW.
Raed Alshammari
Favorite
AlvarezBaron, Claudia
U.S. Food and Drug Administration
PII-217
-
MULTI-CARDIAC ION CHANNEL BLOCK PROFILES FOR LOPINAVIR, RITONAVIR, CHLOROQUINE AND VANOXERINE ALIGN WITH CLINICAL ECG CHANGES AND PROARRHYTHMIA: TWO CASE STUDIES IN SUPPORT OF THE CIPA INITIATIVE.
Claudia AlvarezBaron
Favorite
Back to Top
